BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8385060)

  • 21. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV 18 and cervical adenocarcinomas.
    Bjersing L; Rogo K; Evander M; Gerdes U; Stendahl U; Wadell G
    Anticancer Res; 1991; 11(1):123-7. PubMed ID: 1850213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.
    van Bommel PF; van den Brule AJ; Helmerhorst TJ; Gallee MP; Gaarenstroom KN; Walboomers JM; Meijer CJ; Kenemans P
    Gynecol Oncol; 1993 Mar; 48(3):333-7. PubMed ID: 8385059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
    Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
    Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
    Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
    Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Ki-ras gene mutations within the same tumor using a single tumor crypt in colorectal carcinomas.
    Ishii M; Sugai T; Habano W; Nakamura S
    J Gastroenterol; 2004 Jun; 39(6):544-9. PubMed ID: 15235871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
    Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenocarcinoma in situ of the uterine cervix: clinicopathological study of nine cases with detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction.
    Alejo M; Macedo I; Matias-Guiu X; Prat J
    Int J Gynecol Pathol; 1993 Jul; 12(3):219-23. PubMed ID: 8393844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incidence of point mutations in Ki-ras codon 12 and 13 in squamous epithelial carcinomas of the head-neck region].
    Rathcke IO; Gottschlich S; Görögh T; Lippert BM; Werner JA
    Laryngorhinootologie; 1996 Aug; 75(8):465-70. PubMed ID: 8962608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
    Kato M; Ito Y; Kobayashi S; Isono K
    Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.